Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr David Dodwell

Dr David Dodwell

Contact information

Email
david.dodwell@ndph.ox.ac.uk

Telephone
01865 743562

David Dodwell

BSc, MD, FRCP, FRCR

Senior Clinical Research Fellow

David is a senior breast oncologist with a number of research and governance interests.

He is the lead oncologist on the Sloane and NHS breast screening audits and co-lead for the national audits in primary and metastatic breast cancer.

Recent publications

Reducing locoregional treatments in low risk early invasive breast cancer.

Potter S. et al, (2026), Eur J Surg Oncol, 52

Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-Analysis.

Kazmi F. et al, (2025), Clin Oncol (R Coll Radiol), 48

The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus.

Pfob A. et al, (2025), Lancet Oncol, 26, e694 - e706

Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective.

Hannoun-Levi J-M. et al, (2025), Eur J Surg Oncol, 51

Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence rates.

Kirwan CC. et al, (2025), Eur J Surg Oncol, 51

More publications